Ronald Vagnozzi
Concepts (304)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocytes, Cardiac | 21 | 2025 | 528 | 3.520 |
Why?
| | Myocardium | 12 | 2024 | 1004 | 1.760 |
Why?
| | Fibrosis | 12 | 2024 | 552 | 1.590 |
Why?
| | Macrophages | 10 | 2024 | 1548 | 1.500 |
Why?
| | Ventricular Remodeling | 11 | 2024 | 262 | 1.370 |
Why?
| | Cell- and Tissue-Based Therapy | 2 | 2021 | 82 | 1.320 |
Why?
| | Myocardial Infarction | 10 | 2024 | 1045 | 1.290 |
Why?
| | Stem Cell Transplantation | 2 | 2021 | 177 | 1.250 |
Why?
| | Adult Stem Cells | 2 | 2018 | 41 | 1.170 |
Why?
| | Immunity, Innate | 3 | 2021 | 832 | 1.000 |
Why?
| | Biomedical Research | 2 | 2024 | 689 | 0.950 |
Why?
| | Cell Differentiation | 8 | 2024 | 1979 | 0.850 |
Why?
| | Myofibroblasts | 6 | 2024 | 125 | 0.810 |
Why?
| | Homeostasis | 3 | 2021 | 622 | 0.800 |
Why?
| | Cardiomyopathies | 3 | 2023 | 350 | 0.800 |
Why?
| | Sirtuin 3 | 1 | 2023 | 61 | 0.790 |
Why?
| | Heart | 5 | 2020 | 660 | 0.780 |
Why?
| | American Heart Association | 1 | 2024 | 306 | 0.770 |
Why?
| | T-Lymphocytes | 2 | 2022 | 1999 | 0.760 |
Why?
| | Cardiomyopathy, Restrictive | 1 | 2021 | 10 | 0.740 |
Why?
| | Monocytes | 2 | 2020 | 568 | 0.690 |
Why?
| | Immunity, Humoral | 1 | 2021 | 118 | 0.670 |
Why?
| | Myocarditis | 1 | 2021 | 101 | 0.660 |
Why?
| | Myeloid Cells | 1 | 2020 | 146 | 0.640 |
Why?
| | Immunity, Cellular | 1 | 2021 | 268 | 0.630 |
Why?
| | Antigens, Ly | 1 | 2018 | 44 | 0.610 |
Why?
| | Running | 1 | 2020 | 198 | 0.610 |
Why?
| | Animals | 43 | 2025 | 37011 | 0.600 |
Why?
| | Myocardial Ischemia | 3 | 2015 | 263 | 0.580 |
Why?
| | Mice | 33 | 2025 | 17843 | 0.580 |
Why?
| | Congresses as Topic | 1 | 2019 | 233 | 0.570 |
Why?
| | Immunotherapy | 1 | 2022 | 647 | 0.540 |
Why?
| | Fibroblasts | 5 | 2024 | 990 | 0.520 |
Why?
| | Immunotherapy, Adoptive | 1 | 2019 | 324 | 0.490 |
Why?
| | Glycogen Synthase Kinase 3 | 5 | 2014 | 82 | 0.490 |
Why?
| | Stem Cells | 1 | 2019 | 589 | 0.470 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2019 | 720 | 0.470 |
Why?
| | Membrane Proteins | 2 | 2018 | 1167 | 0.460 |
Why?
| | Disease Models, Animal | 12 | 2024 | 4295 | 0.440 |
Why?
| | Extracellular Matrix | 6 | 2021 | 528 | 0.410 |
Why?
| | MAP Kinase Kinase Kinases | 1 | 2013 | 73 | 0.410 |
Why?
| | Endothelium, Vascular | 2 | 2018 | 923 | 0.400 |
Why?
| | Cardiovascular Diseases | 3 | 2023 | 2113 | 0.400 |
Why?
| | Protein Kinases | 1 | 2013 | 319 | 0.360 |
Why?
| | Mice, Inbred C57BL | 16 | 2024 | 5792 | 0.360 |
Why?
| | Cell Communication | 2 | 2024 | 313 | 0.350 |
Why?
| | Gene Deletion | 5 | 2017 | 393 | 0.350 |
Why?
| | Aging | 5 | 2020 | 1866 | 0.350 |
Why?
| | Rodentia | 2 | 2021 | 57 | 0.340 |
Why?
| | Mice, Transgenic | 10 | 2023 | 2182 | 0.330 |
Why?
| | Myocardial Reperfusion Injury | 2 | 2024 | 134 | 0.310 |
Why?
| | Cell Lineage | 4 | 2020 | 346 | 0.300 |
Why?
| | Regeneration | 4 | 2020 | 195 | 0.290 |
Why?
| | Coronary Vessels | 2 | 2021 | 245 | 0.290 |
Why?
| | Heart Failure | 5 | 2024 | 2222 | 0.290 |
Why?
| | Mitochondria | 5 | 2020 | 947 | 0.270 |
Why?
| | Oxidative Stress | 1 | 2013 | 1307 | 0.260 |
Why?
| | Myocardial Contraction | 4 | 2015 | 343 | 0.260 |
Why?
| | Cells, Cultured | 9 | 2024 | 4206 | 0.250 |
Why?
| | Signal Transduction | 7 | 2024 | 5096 | 0.240 |
Why?
| | Nanotubes, Carbon | 1 | 2025 | 48 | 0.230 |
Why?
| | Azepines | 1 | 2024 | 90 | 0.220 |
Why?
| | Heart Diseases | 2 | 2017 | 359 | 0.220 |
Why?
| | Cell Cycle Proteins | 2 | 2024 | 614 | 0.220 |
Why?
| | Chordata | 1 | 2023 | 5 | 0.210 |
Why?
| | Injections | 2 | 2025 | 182 | 0.210 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2024 | 106 | 0.210 |
Why?
| | Calcium Channels | 2 | 2015 | 165 | 0.210 |
Why?
| | Triazoles | 1 | 2024 | 151 | 0.210 |
Why?
| | Iron-Binding Proteins | 1 | 2023 | 44 | 0.210 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2024 | 368 | 0.200 |
Why?
| | Bone Marrow Transplantation | 2 | 2021 | 286 | 0.200 |
Why?
| | Nuclear Proteins | 2 | 2024 | 710 | 0.200 |
Why?
| | Calcium | 3 | 2015 | 1233 | 0.200 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2024 | 242 | 0.200 |
Why?
| | Collagen Type I | 1 | 2023 | 133 | 0.200 |
Why?
| | Ventricular Function, Right | 1 | 2025 | 283 | 0.200 |
Why?
| | Arteries | 2 | 2023 | 269 | 0.190 |
Why?
| | Ventricular Dysfunction, Left | 3 | 2014 | 389 | 0.190 |
Why?
| | Mitochondrial Membrane Transport Proteins | 2 | 2013 | 43 | 0.190 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2025 | 236 | 0.190 |
Why?
| | Mice, Knockout | 9 | 2024 | 3020 | 0.190 |
Why?
| | Career Choice | 1 | 2024 | 215 | 0.190 |
Why?
| | Hypertension, Pulmonary | 2 | 2025 | 1903 | 0.180 |
Why?
| | Biocompatible Materials | 1 | 2025 | 424 | 0.180 |
Why?
| | Tissue Engineering | 1 | 2025 | 418 | 0.170 |
Why?
| | Phagocytes | 1 | 2021 | 100 | 0.170 |
Why?
| | Chromatin | 1 | 2024 | 524 | 0.170 |
Why?
| | Arteritis | 1 | 2020 | 27 | 0.170 |
Why?
| | Smad3 Protein | 2 | 2017 | 43 | 0.170 |
Why?
| | Treatment Failure | 1 | 2021 | 353 | 0.170 |
Why?
| | Fellowships and Scholarships | 1 | 2024 | 306 | 0.170 |
Why?
| | Bone Marrow Cells | 1 | 2021 | 313 | 0.170 |
Why?
| | Gene Transfer Techniques | 1 | 2021 | 169 | 0.160 |
Why?
| | Persistent Fetal Circulation Syndrome | 1 | 2021 | 137 | 0.160 |
Why?
| | Neovascularization, Physiologic | 1 | 2021 | 177 | 0.160 |
Why?
| | Marfan Syndrome | 1 | 2020 | 41 | 0.160 |
Why?
| | Rejuvenation | 1 | 2019 | 18 | 0.160 |
Why?
| | Muscular Dystrophies, Limb-Girdle | 1 | 2019 | 4 | 0.160 |
Why?
| | HSP47 Heat-Shock Proteins | 1 | 2019 | 6 | 0.160 |
Why?
| | Boston | 1 | 2019 | 92 | 0.160 |
Why?
| | Collagen | 2 | 2019 | 447 | 0.160 |
Why?
| | STAT3 Transcription Factor | 1 | 2021 | 208 | 0.160 |
Why?
| | Humans | 20 | 2025 | 137514 | 0.160 |
Why?
| | Genetic Engineering | 1 | 2019 | 92 | 0.150 |
Why?
| | Cell Adhesion Molecules | 2 | 2020 | 183 | 0.150 |
Why?
| | Myoblasts, Cardiac | 2 | 2018 | 3 | 0.150 |
Why?
| | Pulmonary Alveoli | 1 | 2021 | 405 | 0.150 |
Why?
| | Vascular Remodeling | 2 | 2021 | 190 | 0.150 |
Why?
| | Leukocytes, Mononuclear | 1 | 2021 | 558 | 0.150 |
Why?
| | Heart Valve Diseases | 1 | 2020 | 152 | 0.150 |
Why?
| | Yolk Sac | 1 | 2018 | 5 | 0.150 |
Why?
| | Cell Self Renewal | 1 | 2018 | 54 | 0.140 |
Why?
| | Cell Movement | 3 | 2018 | 972 | 0.140 |
Why?
| | Ischemia | 1 | 2021 | 408 | 0.140 |
Why?
| | Regenerative Medicine | 1 | 2018 | 47 | 0.140 |
Why?
| | Muscle Development | 1 | 2018 | 111 | 0.140 |
Why?
| | Hydrogels | 1 | 2025 | 675 | 0.140 |
Why?
| | Male | 17 | 2025 | 67718 | 0.140 |
Why?
| | Cell Transdifferentiation | 1 | 2017 | 31 | 0.140 |
Why?
| | Smad2 Protein | 1 | 2017 | 38 | 0.140 |
Why?
| | Cicatrix | 1 | 2018 | 64 | 0.140 |
Why?
| | Transcription Factors | 2 | 2024 | 1717 | 0.140 |
Why?
| | Cardiomegaly | 4 | 2023 | 175 | 0.130 |
Why?
| | Proto-Oncogene Proteins c-kit | 2 | 2014 | 67 | 0.130 |
Why?
| | Models, Animal | 1 | 2018 | 387 | 0.130 |
Why?
| | Embryonic Stem Cells | 1 | 2018 | 123 | 0.130 |
Why?
| | Actin Cytoskeleton | 2 | 2015 | 100 | 0.130 |
Why?
| | Dual-Specificity Phosphatases | 1 | 2016 | 11 | 0.130 |
Why?
| | Isoproterenol | 1 | 2016 | 116 | 0.130 |
Why?
| | RNA, Messenger | 2 | 2022 | 2838 | 0.120 |
Why?
| | Cellular Reprogramming | 1 | 2016 | 98 | 0.120 |
Why?
| | Phosphoprotein Phosphatases | 1 | 2015 | 67 | 0.120 |
Why?
| | Aorta, Thoracic | 2 | 2015 | 267 | 0.120 |
Why?
| | Nanoparticles | 1 | 2021 | 484 | 0.120 |
Why?
| | Protein Kinase Inhibitors | 2 | 2013 | 920 | 0.120 |
Why?
| | Enzyme Activation | 2 | 2014 | 816 | 0.120 |
Why?
| | Chronic Disease | 1 | 2021 | 1790 | 0.120 |
Why?
| | Muscle Proteins | 1 | 2016 | 229 | 0.120 |
Why?
| | Transforming Growth Factor beta | 1 | 2017 | 480 | 0.110 |
Why?
| | Aortic Diseases | 1 | 2015 | 117 | 0.110 |
Why?
| | Melanosomes | 1 | 2014 | 2 | 0.110 |
Why?
| | Heart Ventricles | 1 | 2019 | 792 | 0.110 |
Why?
| | Concanavalin A | 1 | 2014 | 76 | 0.110 |
Why?
| | MAP Kinase Signaling System | 1 | 2016 | 322 | 0.110 |
Why?
| | Pigment Epithelium of Eye | 1 | 2014 | 35 | 0.110 |
Why?
| | Heart Injuries | 1 | 2014 | 37 | 0.110 |
Why?
| | Protein Isoforms | 1 | 2015 | 403 | 0.110 |
Why?
| | Niacinamide | 1 | 2014 | 79 | 0.110 |
Why?
| | Phenylurea Compounds | 1 | 2014 | 95 | 0.100 |
Why?
| | Cell Nucleus | 1 | 2016 | 615 | 0.100 |
Why?
| | Superoxides | 1 | 2013 | 202 | 0.100 |
Why?
| | Small Molecule Libraries | 1 | 2013 | 96 | 0.100 |
Why?
| | Cation Transport Proteins | 1 | 2013 | 134 | 0.100 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2013 | 283 | 0.100 |
Why?
| | Calcium-Binding Proteins | 1 | 2013 | 218 | 0.100 |
Why?
| | Cell Proliferation | 5 | 2020 | 2482 | 0.100 |
Why?
| | Heart Rupture | 1 | 2011 | 4 | 0.090 |
Why?
| | Cell Death | 1 | 2013 | 370 | 0.090 |
Why?
| | Sarcopenia | 1 | 2013 | 82 | 0.090 |
Why?
| | Atherosclerosis | 1 | 2015 | 415 | 0.090 |
Why?
| | Female | 8 | 2025 | 73162 | 0.090 |
Why?
| | Up-Regulation | 1 | 2013 | 846 | 0.090 |
Why?
| | Cyclophilins | 1 | 2010 | 40 | 0.080 |
Why?
| | Acute Coronary Syndrome | 1 | 2013 | 275 | 0.080 |
Why?
| | Single-Cell Analysis | 2 | 2024 | 309 | 0.080 |
Why?
| | Indoles | 2 | 2013 | 415 | 0.080 |
Why?
| | Treatment Outcome | 2 | 2021 | 10821 | 0.080 |
Why?
| | Pyrroles | 1 | 2009 | 211 | 0.070 |
Why?
| | Energy Metabolism | 1 | 2013 | 895 | 0.070 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2009 | 197 | 0.070 |
Why?
| | Primary Cell Culture | 2 | 2019 | 172 | 0.060 |
Why?
| | Endothelial Cells | 3 | 2019 | 780 | 0.060 |
Why?
| | Animals, Newborn | 2 | 2020 | 845 | 0.060 |
Why?
| | Phenotype | 3 | 2024 | 3205 | 0.060 |
Why?
| | Hematopoietic Stem Cells | 2 | 2020 | 398 | 0.060 |
Why?
| | Cell Fusion | 2 | 2016 | 51 | 0.060 |
Why?
| | CX3C Chemokine Receptor 1 | 1 | 2024 | 19 | 0.060 |
Why?
| | Inflammation | 1 | 2015 | 2837 | 0.060 |
Why?
| | Transcription Factor RelA | 1 | 2024 | 88 | 0.060 |
Why?
| | Lipoylation | 1 | 2023 | 17 | 0.050 |
Why?
| | Particle Size | 1 | 2025 | 394 | 0.050 |
Why?
| | Histidine | 1 | 2023 | 65 | 0.050 |
Why?
| | Acyltransferases | 1 | 2023 | 56 | 0.050 |
Why?
| | Materials Testing | 1 | 2025 | 357 | 0.050 |
Why?
| | Enhancer Elements, Genetic | 1 | 2024 | 190 | 0.050 |
Why?
| | Echocardiography | 2 | 2021 | 659 | 0.050 |
Why?
| | Gene Expression Profiling | 2 | 2020 | 1770 | 0.050 |
Why?
| | Heart Atria | 1 | 2023 | 136 | 0.050 |
Why?
| | Antineoplastic Agents | 1 | 2014 | 2145 | 0.050 |
Why?
| | Interleukin-1beta | 1 | 2024 | 373 | 0.050 |
Why?
| | Rats | 3 | 2019 | 5676 | 0.050 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2025 | 249 | 0.050 |
Why?
| | Temperature | 1 | 2025 | 680 | 0.050 |
Why?
| | Acclimatization | 1 | 2023 | 176 | 0.050 |
Why?
| | Membrane Potential, Mitochondrial | 2 | 2013 | 71 | 0.050 |
Why?
| | Theranostic Nanomedicine | 1 | 2021 | 15 | 0.050 |
Why?
| | Airway Remodeling | 1 | 2021 | 64 | 0.040 |
Why?
| | NF-kappa B | 1 | 2024 | 694 | 0.040 |
Why?
| | Homeodomain Proteins | 1 | 2024 | 504 | 0.040 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 2021 | 145 | 0.040 |
Why?
| | Transplantation Chimera | 1 | 2020 | 54 | 0.040 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 2 | 2013 | 125 | 0.040 |
Why?
| | Forkhead Transcription Factors | 1 | 2021 | 191 | 0.040 |
Why?
| | Drug Carriers | 1 | 2021 | 129 | 0.040 |
Why?
| | Fibrillin-1 | 1 | 2020 | 6 | 0.040 |
Why?
| | Angiotensin II | 1 | 2020 | 99 | 0.040 |
Why?
| | Hypertrophy | 1 | 2020 | 134 | 0.040 |
Why?
| | Disease Progression | 2 | 2020 | 2755 | 0.040 |
Why?
| | Leukocyte Common Antigens | 1 | 2020 | 87 | 0.040 |
Why?
| | Sarcoglycans | 1 | 2019 | 5 | 0.040 |
Why?
| | Multiprotein Complexes | 2 | 2013 | 163 | 0.040 |
Why?
| | Chemokine CCL2 | 1 | 2020 | 117 | 0.040 |
Why?
| | Mitral Valve | 1 | 2020 | 89 | 0.040 |
Why?
| | Disease Susceptibility | 1 | 2021 | 344 | 0.040 |
Why?
| | Genetic Therapy | 1 | 2021 | 296 | 0.040 |
Why?
| | Bone Marrow | 1 | 2020 | 286 | 0.040 |
Why?
| | Zebrafish | 1 | 2023 | 496 | 0.040 |
Why?
| | Sex Factors | 1 | 2025 | 2074 | 0.040 |
Why?
| | Dogs | 1 | 2020 | 411 | 0.040 |
Why?
| | Blood Circulation | 1 | 2018 | 41 | 0.040 |
Why?
| | Epigenesis, Genetic | 1 | 2023 | 660 | 0.040 |
Why?
| | TOR Serine-Threonine Kinases | 2 | 2013 | 414 | 0.040 |
Why?
| | Drug Delivery Systems | 1 | 2021 | 363 | 0.040 |
Why?
| | Sequence Analysis, RNA | 1 | 2020 | 451 | 0.030 |
Why?
| | Receptors, Transforming Growth Factor beta | 1 | 2017 | 59 | 0.030 |
Why?
| | Swine | 1 | 2020 | 775 | 0.030 |
Why?
| | Embryo, Mammalian | 1 | 2018 | 232 | 0.030 |
Why?
| | Mice, Inbred mdx | 1 | 2016 | 13 | 0.030 |
Why?
| | Organ Specificity | 1 | 2017 | 304 | 0.030 |
Why?
| | Extracellular Matrix Proteins | 1 | 2018 | 153 | 0.030 |
Why?
| | Microscopy, Confocal | 1 | 2018 | 327 | 0.030 |
Why?
| | Gene Expression Regulation | 2 | 2016 | 2615 | 0.030 |
Why?
| | Muscle, Skeletal | 2 | 2019 | 1701 | 0.030 |
Why?
| | Catecholamines | 1 | 2016 | 98 | 0.030 |
Why?
| | Mice, 129 Strain | 1 | 2016 | 88 | 0.030 |
Why?
| | Time Factors | 2 | 2018 | 6817 | 0.030 |
Why?
| | Protein Phosphatase 2C | 1 | 2015 | 15 | 0.030 |
Why?
| | Ventricular Myosins | 1 | 2015 | 35 | 0.030 |
Why?
| | Gene Knock-In Techniques | 1 | 2015 | 56 | 0.030 |
Why?
| | Apolipoproteins E | 1 | 2015 | 84 | 0.030 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2020 | 856 | 0.030 |
Why?
| | Myofibrils | 1 | 2015 | 49 | 0.030 |
Why?
| | Sarcomeres | 1 | 2015 | 95 | 0.030 |
Why?
| | Apoptosis | 2 | 2014 | 2557 | 0.030 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2016 | 216 | 0.030 |
Why?
| | Plaque, Atherosclerotic | 1 | 2015 | 57 | 0.030 |
Why?
| | Proteins | 2 | 2013 | 1012 | 0.030 |
Why?
| | Microfilament Proteins | 1 | 2015 | 131 | 0.030 |
Why?
| | In Situ Nick-End Labeling | 1 | 2014 | 124 | 0.030 |
Why?
| | Cytoplasmic Streaming | 1 | 2014 | 2 | 0.030 |
Why?
| | Diet, High-Fat | 1 | 2015 | 248 | 0.030 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2014 | 72 | 0.030 |
Why?
| | Metoprolol | 1 | 2014 | 40 | 0.030 |
Why?
| | Cell Aggregation | 1 | 2014 | 26 | 0.030 |
Why?
| | Perciformes | 1 | 2014 | 17 | 0.030 |
Why?
| | Cats | 1 | 2014 | 211 | 0.030 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2015 | 260 | 0.030 |
Why?
| | Cell Line | 1 | 2019 | 2852 | 0.030 |
Why?
| | Integrases | 1 | 2014 | 121 | 0.030 |
Why?
| | Maleimides | 1 | 2013 | 23 | 0.030 |
Why?
| | Amino Acid Motifs | 1 | 2013 | 225 | 0.030 |
Why?
| | Tamoxifen | 1 | 2014 | 202 | 0.030 |
Why?
| | Muscle, Smooth, Vascular | 1 | 2015 | 446 | 0.030 |
Why?
| | Everolimus | 1 | 2013 | 91 | 0.020 |
Why?
| | Adenosine Triphosphate | 1 | 2015 | 487 | 0.020 |
Why?
| | Protein Multimerization | 1 | 2013 | 193 | 0.020 |
Why?
| | In Vitro Techniques | 1 | 2014 | 1108 | 0.020 |
Why?
| | HeLa Cells | 1 | 2013 | 640 | 0.020 |
Why?
| | Hepatocytes | 1 | 2013 | 220 | 0.020 |
Why?
| | Stress, Physiological | 1 | 2015 | 445 | 0.020 |
Why?
| | RNA, Small Interfering | 1 | 2014 | 621 | 0.020 |
Why?
| | Sirolimus | 1 | 2013 | 275 | 0.020 |
Why?
| | Cellular Senescence | 1 | 2013 | 188 | 0.020 |
Why?
| | Cardiotonic Agents | 1 | 2011 | 126 | 0.020 |
Why?
| | Death | 1 | 2011 | 119 | 0.020 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2011 | 188 | 0.020 |
Why?
| | Phosphorylation | 1 | 2015 | 1762 | 0.020 |
Why?
| | Kaplan-Meier Estimate | 1 | 2013 | 892 | 0.020 |
Why?
| | Autophagy | 1 | 2013 | 282 | 0.020 |
Why?
| | Binding Sites | 1 | 2013 | 1310 | 0.020 |
Why?
| | Bone and Bones | 1 | 2013 | 317 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2014 | 1740 | 0.020 |
Why?
| | Mitochondria, Heart | 1 | 2010 | 100 | 0.020 |
Why?
| | Biomarkers | 1 | 2021 | 4172 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2014 | 2066 | 0.020 |
Why?
| | Knee Joint | 1 | 2013 | 405 | 0.020 |
Why?
| | Inhibitory Concentration 50 | 1 | 2009 | 90 | 0.020 |
Why?
| | Myosin Heavy Chains | 1 | 2010 | 191 | 0.020 |
Why?
| | Exons | 1 | 2010 | 349 | 0.020 |
Why?
| | Vasoconstriction | 1 | 2010 | 202 | 0.020 |
Why?
| | Capillaries | 1 | 2009 | 108 | 0.020 |
Why?
| | Cell Division | 1 | 2010 | 795 | 0.020 |
Why?
| | DNA | 1 | 2014 | 1460 | 0.020 |
Why?
| | Protein Binding | 1 | 2013 | 2229 | 0.020 |
Why?
| | Models, Biological | 1 | 2014 | 1775 | 0.020 |
Why?
| | Cell Survival | 1 | 2009 | 1122 | 0.010 |
Why?
| | Promoter Regions, Genetic | 1 | 2010 | 1255 | 0.010 |
Why?
| | Biopsy | 1 | 2009 | 1132 | 0.010 |
Why?
| | Liver | 1 | 2013 | 1940 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 2009 | 2501 | 0.010 |
Why?
| | Adult | 1 | 2023 | 37821 | 0.010 |
Why?
| | Aged | 1 | 2014 | 23798 | 0.010 |
Why?
| | Middle Aged | 1 | 2014 | 33355 | 0.010 |
Why?
|
|
Vagnozzi's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|